Your browser doesn't support javascript.
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
Atanackovic, Djordje; Luetkens, Tim; Omili, Destiny; Iraguha, Thierry; Lutfi, Forat; Hardy, Nancy M; Fan, Xiaoxuan; Avila, Stephanie V; Saharia, Kapil K; Husson, Jennifer S; Niederhaus, Silke V; Margiotta, Philip; Lee, Seung T; Law, Jennie Y; Mannuel, Heather D; Vander Mause, Erica; Bauman, Sherri; Lesho, Patricia; Hankey, Kim; Baddley, John; Kocoglu, Mehmet; Yared, Jean A; Rapoport, Aaron P; Dahiya, Saurabh.
  • Atanackovic D; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • Luetkens T; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Omili D; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.
  • Iraguha T; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • Lutfi F; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Hardy NM; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.
  • Fan X; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • Avila SV; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Saharia KK; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • Husson JS; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Niederhaus SV; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Margiotta P; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • Lee ST; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Law JY; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.
  • Mannuel HD; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Vander Mause E; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • Bauman S; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Lesho P; Institute of Human Virology.
  • Hankey K; Divison of Infectious Diseases, and.
  • Baddley J; Institute of Human Virology.
  • Kocoglu M; Divison of Infectious Diseases, and.
  • Yared JA; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD; and.
  • Rapoport AP; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
  • Dahiya S; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
Blood ; 140(2): 152-156, 2022 07 14.
Artículo en Inglés | MEDLINE | ID: covidwho-1869038
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 / Linfoma Tópicos: Vacunas / Variantes Límite: Humanos Idioma: Inglés Revista: Blood Año: 2022 Tipo del documento: Artículo País de afiliación: Blood.2022016175

Similares

MEDLINE
LILACS
LIS
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 / Linfoma Tópicos: Vacunas / Variantes Límite: Humanos Idioma: Inglés Revista: Blood Año: 2022 Tipo del documento: Artículo País de afiliación: Blood.2022016175